Navigation Links
Regenerative Medicine | Bill Nye the Science Guy Got PRP Therapy for “Dancing With The Stars” Injury
Date:1/15/2014

Los Angeles, CA (PRWEB) January 15, 2014

After suffering a leg injury during a fall on “Dancing With the Stars,” Bill Nye the Science Guy received an innovative treatment known as platelet-rich plasma therapy (PRP) in the hope of returning to the stage in the subsequent week. Return he did, and he brought with him a layman’s explanation of PRP, the kind of science-made-simple description his legions of fans know him for.

According to Nye, he received “platelet-rich plasma, which is where they take platelets from your blood in your arm, and poke them into the tendon and to-be-repaired area. It excites the cells in the right way to bring ‘em around faster than they would otherwise.”

Say James Hays, President and CEO of PlasmaGenix, Inc. in Los Angeles, “Mr. Nye’s description is nearly spot on in terms of how regenerative medicine speeds healing — though I’d suggest that the next time he needs a treatment, he pays a visit to our offices. We don’t ‘poke’ our patients anywhere during PRP therapy!”

Dr. John Simmonds, an orthopedic surgeon and Chief Medical Officer, further explains the technicalities of how PRP works. “The procedure starts by drawing blood from a patient. This blood is spun in a centrifuge to concentrate the platelets and growth factors. When injected into the site of an injury, the PRP has the potential to supercharge the healing process and reduce pain.”

About PlasmaGenix

PlasmaGenix is a biologics company located in Inglewood, California. Our three lead products, PlasmaNeu, PlasmaGen and PlasmaPro, have been used for over a decade to treat chronic non-healing wounds and preventing amputations in high risk populations, and peripheral neuropathy associated with HIV and Diabetes. Science has recently shown that the body has enormous potential to heal itself. Regenerative medicine is an exciting area in medicine that is evolving very rapidly and PlasmaGenix is proud to be at the forefront of developing new therapeutics to treat a wide variety of chronic conditions. We can now deliver products to accelerate the body’s own natural healing mechanisms and enrich the body’s inherent ability to repair and regenerate.

The culmination of over 3 decades of clinical experience and research gave birth to PlasmaGenix which is poised to be a leader in the field of regenerative medicine. To date, PlasmaGenix has successfully treated over 10,000 patients for various neurologic conditions, chronic non-healing wounds, sports related injures as well as muscular sclerosis and Charcot-Marie Tooth disease.

Read the full story at http://www.prweb.com/releases/2014/01/prweb11482238.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. The American Academy of Anti-Aging Medicine (A4M) Concludes Largest Event in Anti-Aging, Regenerative and Aesthetic Medicine on Sunday, December 15, 2013
2. Regenerative medicine: Mayo Clinic and collaborators develop new tool for transplanting stem cells
3. More Efficient Way to Grow Heart Muscle from Stem Cells Could Yield New Regenerative Therapies
4. Regenerative Agriculture Products & Services Company, Advancing Eco Agriculture, Discuss Initiative to Test Regenerative Practices to Restore Soil Quality
5. Mayo Clinic researchers apply regenerative medicine to battlefield injuries
6. Institute for regenerative medicine to lead national effort to aid wounded warriors
7. Regenerative Medicines: Bone and Joint Applications
8. The American Academy of Anti-Aging Medicine (A4M) Will Travel to Bangkok Congress on Anti-Aging and Regenerative Medicine September 6-8, 2013 for Largest Asian Event
9. New Biotechnology Report: Regenerative Medicine Markets
10. Gene therapies for regenerative surgery are getting closer, says review in PRS
11. The Institute of Regenerative & Molecular Orthopedics Applauds Newly Released Study on Platelet-Rich Plasma
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... blind and certified personal trainer is helping to develop a weight loss fitness plan that ... the two major problems leading the fitness industry today:, , All ... They don’t eliminate all the reasons people quit their exercise program , ...
(Date:6/25/2016)... ... June 25, 2016 , ... ... issues and applications at AcademyHealth’s Annual Research Meeting June 26-28, 2016, at the ... several important health care topics including advance care planning, healthcare costs and patient ...
(Date:6/25/2016)... (PRWEB) , ... June 25, 2016 , ... The temporary closing of Bruton Memorial Library ... City Observer , brings up a new, often overlooked aspect of head lice: the parasite’s ... for fumigation is not a common occurrence, but a necessary one in the event that ...
(Date:6/25/2016)... ... 2016 , ... First Choice Emergency Room , the largest network of ... Medical Director of its new Mesquite-Samuell Farm facility. , “We are pleased to ... said Dr. James M. Muzzarelli, Executive Medical Director of First Choice Emergency Room. ...
(Date:6/25/2016)... ... June 25, 2016 , ... Dr. Calvin Johnson has ... he has implemented orthobiologic procedures as a method for treating his patients. The ... first doctors to perform the treatment. Orthobiologics are substances that orthopaedic surgeons use ...
Breaking Medicine News(10 mins):
(Date:6/26/2016)... June 27, 2016  VMS Rehab Systems, Inc. ( ... take whatever measures required to build a strong and ... is currently listed on the OTC Markets-pink current trading ... and CEO, "We are seeing an anomaly in market ... not only by the Company, but shareholders and market ...
(Date:6/24/2016)... June 24, 2016  Global Blood Therapeutics, Inc. (GBT) ... developing novel therapeutics for the treatment of grievous ... the closing of its previously announced underwritten public ... the public offering price of $18.75 per share. ... offered by GBT. GBT estimates net proceeds from ...
(Date:6/24/2016)... June 24, 2016 The Academy of Managed ... recommendations that would allow biopharmaceutical companies to more ... that make formulary and coverage decisions, a move that ... new medicines. The recommendations address restrictions in ... on the drug label, a prohibition that hinders decision ...
Breaking Medicine Technology: